Prognostic utility of a geriatric nutritional risk index in combination with a comorbidity index in elderly patients with diffuse large B cell lymphoma

被引:31
|
作者
Lee, Shin [1 ,2 ]
Fujita, Kei [1 ,2 ]
Morishita, Tetsuji [3 ,4 ]
Negoro, Eiju [1 ]
Oiwa, Kana [1 ,5 ]
Tsukasaki, Hikaru [6 ]
Yamamura, Osamu [7 ]
Ueda, Takanori [1 ]
Yamauchi, Takahiro [1 ]
机构
[1] Univ Fukui, Fac Med Sci, Dept Hematol & Oncol, Fukui, Japan
[2] Matsunami Gen Hosp, Dept Hematol, Gifu, Japan
[3] Univ Fukui, Fac Med Sci, Dept Cardiovasc Med, Fukui, Japan
[4] Natl Hosp Org Awara Hosp, Dept Cardiovasc Med, Fukui, Japan
[5] Nagoya City Univ, Dept Hematol & Oncol, Nagoya, Aichi, Japan
[6] Fukui Red Cross Hosp, Dept Hematol, Fukui, Japan
[7] Univ Fukui, Fac Med Sci, Dept Internal Med 2, Fukui, Japan
关键词
DLBCL; GNRI; CCI; net reclassification improvement; integrated discrimination improvement; decision curve analysis; UNITED-STATES; SURVIVAL; PATTERNS; CURVE;
D O I
10.1111/bjh.16743
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reflecting the increasing risk in elderly patients with diffuse large B cell lymphoma (DLBCL), prognostic predictors other than the International Prognostic Index have attracted more attention. This study presents the first analysis of the prognostic utility of the Geriatric Nutritional Risk Index (GNRI) in combination with the Charlson Comorbidity Index (CCI) for overall survival (OS) in elderly DLBCL patients. A multicentre retrospective was conducted on a cohort of 451 patients (>= 65 years). The GNRI and CCI were independent predictors in a multivariate Cox proportional hazard model. There was a nonlinear correlation between the GNRI and OS in a Cox model with restricted cubic spline. Multivariate receiver operating characteristic curves showed a significant improvement in prediction accuracy when the GNRI was added to CCI. Adding the GNRI to CCI yielded a significant category-free net reclassification improvement (0 center dot 556; 95% CI: 0 center dot 378-0 center dot 736, P < 0 center dot 001) and integrated discrimination improvement (0 center dot 094; 95% CI: 0 center dot 067-0 center dot 122, P < 0 center dot 001). The decision curve analysis demonstrated the clinical net benefit associated with the adoption of the GNRI. The GNRI was not only a predictor of OS but also remarkably improved the prognosis prediction accuracy when incorporated with the CCI, having the ability to stratify the prognosis of elderly DLBCL patients.
引用
收藏
页码:100 / 109
页数:10
相关论文
共 50 条
  • [41] Enhanced International Prognostic Index (NCCN-IPI), Charlson Comorbidity Index and absolute lymphocyte count as predictors for survival of elderly patients with diffuse large B cell lymphoma treated by immunochemotherapy
    Jelicic, J.
    Balint, M. Todorovic
    Antic, D.
    Sretenovic, A.
    Balint, B.
    Jovanovic, M. Perunicic
    Andjelic, B.
    Vukovic, V.
    Djurasinovic, V.
    Bila, J.
    Pavlovic, M.
    Smiljanic, M.
    Mihaljevic, B.
    NEOPLASMA, 2015, 62 (06) : 988 - 995
  • [42] Prognostic nutritional index, a novel biomarker which predicts worse prognosis in diffuse large B cell lymphoma
    He, Jie
    Yin, Hua
    Xia, Yi
    Wu, Jia-Zhu
    Liang, Jin-Hua
    Zhu, Hua-Yuan
    Fan, Lei
    Li, Jian-Yong
    Wang, Li
    Xu, Wei
    LEUKEMIA RESEARCH, 2021, 110
  • [43] Prognostic value of geriatric nutritional risk index and prognostic nutritional index in hepatocellular carcinoma
    Yang, Cheng-Kun
    Huang, Ke-Tuan
    Qin, Wei
    Wu, Qiong-Yuan
    Huang, Xin-Lei
    Peng, Kai
    Lao, Quan
    Ye, Xin-Ping
    Zhu, Guang-Zhi
    Li, Tian-Man
    Peng, Tao
    CLINICAL NUTRITION ESPEN, 2024, 59 : 355 - 364
  • [44] Prognostic Scoring Systems in Diffuse Large B Cell Lymphoma Patients - Is Kyoto Prognostic Index an Added Value?
    Gomes, Marilia
    Duarte, Sara
    Afonso, Carolina
    Neves, Dulcelena
    Marques, Barbara Almeida
    Lima, Carla Barros
    Roque, Adriana
    Lai, Ana Catarina
    Ruzickova, Lenka
    Juliao, Maria Jose
    Carda, Jose Pedro
    Espadana, Ana
    BLOOD, 2021, 138
  • [45] Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index
    Mikhaeel, N. George
    Heymans, Martijn W.
    Eertink, Jakoba J.
    de Vet, Henrica C. W.
    Boellaard, Ronald
    Duhrsen, Ulrich
    Ceriani, Luca
    Schmitz, Christine
    Wiegers, Sanne E.
    Huttmann, Andreas
    Lugtenburg, Pieternella J.
    Zucca, Emanuele
    Zwezerijnen, Gerben J. C.
    Hoekstra, Otto S.
    Zijlstra, Josee M.
    Barrington, Sally F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (21) : 2352 - +
  • [46] Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study
    Huang, Hong-Hui
    Xiao, Fei
    Chen, Fang-Yuan
    Wang, Ting
    Li, Jun-Min
    Wang, Jian-Min
    Cao, Jun-Ning
    Wang, Chun
    Zou, Shan-Hua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2012, 4 (03) : 473 - 478
  • [47] Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients
    Bouillanne, O
    Morineau, G
    Dupont, C
    Coulombel, I
    Vincent, JP
    Nicolis, I
    Benazeth, S
    Cynober, L
    Aussel, C
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (04): : 777 - 783
  • [48] PROPOSAL OF NEW PROGNOSTIC INDEX FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Yoon, S.
    Yoon, D. H.
    Kim, S.
    Lee, K.
    Kang, E. H.
    Lee, S. W.
    Park, C. J.
    Park, C. S.
    Huh, J.
    Suh, C.
    HAEMATOLOGICA, 2015, 100 : 403 - 404
  • [49] Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphoma
    Niiyama-Uchibori, Yui
    Okamoto, Haruya
    Miyashita, Akihiro
    Mizuhara, Kentaro
    Kanayama-Kawaji, Yuka
    Fujino, Takahiro
    Tsukamoto, Taku
    Mizutani, Shinsuke
    Shimura, Yuji
    Teramukai, Satoshi
    Kuroda, Junya
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (01)
  • [50] Proposal of New Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Yoon, Shinkyo
    Yoon, Dok Hyun
    Kim, Shin
    Lee, Kyoungmin
    Kang, Eun Hee
    Lee, Sang-wook
    Park, Chan-Jeoung
    Park, Chan-Sik
    Huh, Jooryung
    Suh, Cheolwon
    BLOOD, 2014, 124 (21)